EZH2 and acute myeloid leukemia: On the contrary, EZH2 is frequently overexpressed in AML with complex phenotype [33], whereas EZH2 deletion decreases proliferation and promotes apoptosis in MLL-AF9 transformed cells, and delays the progression of AML in transgenic mice [29].